[Synthesis and anti-tumor activity of ursolic acid derivatives]
- PMID: 21800543
[Synthesis and anti-tumor activity of ursolic acid derivatives]
Abstract
Structure of natural product-ursolic acid was modified for increasing its antitumor activity. Ursolic acid was acylated, esterified, hydrolized or oxidized to obtain target pentacyclic triterpenoid compounds with different substitutes. Sixteen derivatives of ursolic acid were designed and synthesized including eleven new compounds. Anti-tumor activities of ursolic acid and these derivatives against HeLa, SKOV3 and BGC-823 cells in vitro were investigated by MTT assay. The results indicated that compounds 7a and 8a were found to have stronger cell growth inhibitory than ursolic acid on HeLa cells and SKOV3 cells separately, and are worth to be intensively studied further.
Similar articles
-
The synthesis of ursolic acid derivatives with cytotoxic activity and the investigation of their preliminary mechanism of action.Bioorg Med Chem. 2009 Jan 15;17(2):848-54. doi: 10.1016/j.bmc.2008.11.036. Epub 2008 Nov 20. Bioorg Med Chem. 2009. PMID: 19091579
-
The cytotoxic activity of ursolic acid derivatives.Eur J Med Chem. 2005 Jun;40(6):582-9. doi: 10.1016/j.ejmech.2005.01.001. Eur J Med Chem. 2005. PMID: 15922841
-
Synthesis of novel ursolic acid heterocyclic derivatives with improved abilities of antiproliferation and induction of p53, p21waf1 and NOXA in pancreatic cancer cells.Bioorg Med Chem. 2012 Oct 1;20(19):5774-86. doi: 10.1016/j.bmc.2012.08.010. Epub 2012 Aug 16. Bioorg Med Chem. 2012. PMID: 22959527
-
Triterpenoids as new promising anticancer drugs.Anticancer Drugs. 2009 Nov;20(10):880-92. doi: 10.1097/CAD.0b013e328330fd90. Anticancer Drugs. 2009. PMID: 19745720 Review.
-
Evolution in medicinal chemistry of ursolic acid derivatives as anticancer agents.Eur J Med Chem. 2015 Mar 6;92:648-55. doi: 10.1016/j.ejmech.2015.01.031. Epub 2015 Jan 16. Eur J Med Chem. 2015. PMID: 25617694 Free PMC article. Review.